| 货号 | HV612086 |
|---|
| 产品名称 | Research Grade Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334) |
|---|
| 中文品名/别名 | Ibi334, Ibi 334 |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | Human |
|---|
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | CD276 antigen, 4Ig-B7-H3, B7 homolog 3, B7-H3, Costimulatory molecule, CD276, CD276, Epidermal growth factor receptor, EC:2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR |
|---|
| 基因号 | Q5ZPR3 & P00533 |
|---|
| 宿主/表达体系 | Human |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334) ( HV612086 ) is a research-grade recombinant antibody targeting CD276 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|